Voltar
Artigo Revisado por pares
BIBTEX RIS

Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study

2019; Springer Science+Business Media; Volume: 146; Issue: 1 Linguagem: Inglês

10.1007/s11060-019-03334-5

ISSN

1573-7373

Autores

Harry Pinson, Giorgio Hallaert, Jan van der Meulen, Franceska Dedeurwaerdere, Dimitri Vanhauwaert, C. Van den Broecke, Jo Van Dorpe, Dirk Van Roost, Jean-Pierre Kalala, Tom Boterberg,

Tópico(s)

MicroRNA in disease regulation

Referência(s)